3IP
CNMD icon

3Chopt Investment Partners’s CONMED CNMD Stock Holding History

3Chopt Investment Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-300
Closed -$26.7K – 162
2022
Q4 		$26.7K Buy
+300
New +$24.9K 0.01% 231

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

3Chopt Investment Partners's CNMD Position: Q1 2023 in Review

3Chopt Investment Partners sold out of CONMED (CNMD) in Q1 2023, closing a stake of 300 shares — an estimated $26.7K sold.

3Chopt Investment Partners first reported a position in CNMD in Q4 2022 and held it in 1 quarter. The position peaked at $26.7K in Q4 2022. 233 funds tracked by Wall St. Rank hold CNMD as of Q1 2023.

  • 3Chopt Investment Partners reported no remaining CONMED position as of Q1 2023 after selling out during the quarter.
  • 3Chopt Investment Partners sold 300 CONMED shares in Q1 2023, an estimated $26.7K.
  • 3Chopt Investment Partners first reported a position in CONMED in Q4 2022 and held it in 1 quarter.
  • 3Chopt Investment Partners's CONMED position peaked at $26.7K in Q4 2022.
  • 233 funds tracked by Wall St. Rank held CONMED as of Q1 2023.

Based on 3Chopt Investment Partners's 13F filing for Q1 2023, filed 23 May 2023.